Status:
COMPLETED
Evaluation of Efficacy and Safety of AGP on Immune Enhancement
Lead Sponsor:
Chonbuk National University Hospital
Conditions:
Immune Function
Eligibility:
All Genders
20-75 years
Phase:
NA
Brief Summary
The researchers investigated the immune enhancing effects of AGP for Korean participants.
Detailed Description
The aim of the study is to investigate the effects of AGP on immune enhancement based on 8 week, randomized, double-blind, placebo-controlled clinical trial.
Eligibility Criteria
Inclusion
- The levels of white blood cells within range 3x10\^3/μL\~8x10\^3/μL
- have had at least two cold in the last 12 months.
Exclusion
- subjects with BMI\<18.5 kg/m\^2
- subjects taking medications such as immune related drug or functional foods
- history of disease that could interfere with the test products or impede their absorption
- pregnant or lactating women and heavy smokers.
- being judged by the responsible physician of the local study center as unfit to participate in the study
Key Trial Info
Start Date :
July 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 27 2017
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03330392
Start Date
July 1 2017
End Date
October 27 2017
Last Update
November 8 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Trial Center for Functional Foods Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea, 54907